Paratek to Receive $4 Million Payment From Actavis With Initiation of Phase 3 Trial of Sarecycline

<b>http://tinyurl.com/o7tzx4q - <a href='http://tinyurl.com/o7tzx4q'>Elevator company launches new lift which arrives quicker the more you press ...</a></b><p>&#39;We are bored with just installing security cameras and then watching footage of people squeezing their blackheads in the lift mirrors.&#39; The technology is also being adapted for Pedestrian Light-Controlled Crossings, where a camera will monitor ...</p><B>Paratek to Receive $4 Million Payment From Actavis With Initiation of Phase 3 ...</b><p>Acne vulgaris is a chronic inflammatory dermatosis which is notable for open and/or closed comedones (blackheads and whiteheads) and inflammatory lesions including papules, pustules, or nodules. Acne occurs most commonly during adolescence and&nbsp;...and more&nbsp;&raquo;</p><B>Paratek to Receive $4 Million Payment From Actavis With Initiation of Phase 3 Trial of Sarecycline</b><p>BOSTON Paratek Pharmaceuticals, Inc. today announced Actavis will be making a $4 million milest
one payment to Paratek under the terms of the parties&#39; collaboration for the development of sarecycline ...</p>